We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $282M
1-Year Est. Return 11.4%
This Fund
S&P 500
This Quarter Est. Return
-8.36%
1 Year Est. Return
+11.4%
3 Year Est. Return
+109.86%
5 Year Est. Return
+194.68%
10 Year Est. Return
AUM
$128M
AUM Growth
-$17.1M
Cap. Flow
-$47.4M
Cap. Flow %
-36.97%
Top 10 Hldgs %
50.52%
Holding
100
New
14
Increased
2
Reduced
4
Closed
34

Sector Composition

Rank Sector Weight
1 Miscellaneous 63.32%
2 Healthcare 12.27%
3 Financials 11.94%
4 Technology 5.54%
5 Materials 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LATGW
51
DELISTED
LatAmGrowth SPAC Warrants
LATGW
$400K 0.31%
37,499
JGGCW
52
DELISTED
Jaguar Global Growth Corporation I Warrant
JGGCW
$397K 0.31%
37,499
CCVI.WS
53
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$350K 0.27%
33,999
SCRMW
54
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$344K 0.27%
33,331
COCHW icon
55
Envoy Medical Warrant
COCHW
$792K
$342K 0.27%
33,332
ALVOW icon
56
Alvotech Warrant
ALVOW
$98.8M
$335K 0.26%
43,287
FRXB.WS
57
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$289K 0.23%
28,199
ASBPW
58
Aspire-Lakewood Holdings, Inc. Warrant
ASBPW
$264K 0.21%
24,999
KYCHW
59
DELISTED
Keyarch Acquisition Corporation Warrant
KYCHW
$209K 0.16%
19,998
LSBPW
60
DELISTED
LakeShore Biopharma Warrants
LSBPW
$207K 0.16%
149,999
AAC.WS
61
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$169K 0.13%
15,999
BBAI.WS icon
62
BigBear.ai Holdings Warrant
BBAI.WS
$15.6M
$157K 0.12%
66,665
SDSTW
63
Stardust Power Inc Warrant
SDSTW
$3.95M
$142K 0.11%
13,333
PIIIW icon
64
P3 Health Partners Inc Warrant
PIIIW
$78.4K
$130K 0.1%
43,334
JGGCR
65
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$11K 0.01%
75,000
KYCHR
66
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$6K ﹤0.01%
40,000
ACI icon
67
Albertsons Companies
ACI
$6.23B
-30,000
Closed -$623K
FHN icon
68
CALL
First Horizon
FHN
$11.6B
-242,800
Closed -$4.32M
FHN icon
69
First Horizon
FHN
$11.6B
-20,000
Closed -$356K
MTAL
70
DELISTED
Metals Acquisition
MTAL
-24,900
Closed -$254K
NRG icon
71
CALL
NRG Energy
NRG
$22.3B
-75,000
Closed -$2.57M
TSEM icon
72
Tower Semiconductor
TSEM
$22.1B
-60,000
Closed -$2.48M
ASBP
73
Aspire-Lakewood Holdings, Inc. Common Stock
ASBP
$11.5M
-42
Closed -$525K
SPWRW
74
SunPower Inc Warrants
SPWRW
$357K
-33,265
Closed -$343K
LATG
75
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
-75,000
Closed -$785K

Similar funds

Athos Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Athos Capital held 100 positions worth $128M, down 12% from $145M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Athos Capital withdrew a net $47.4M in Q2 2023, closing 34 positions and reducing 4 holdings. Its most notable exit was HH&L Acquisition Co., an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Athos Capital opened a new position in Globus Medical worth $3.52M.

  • Athos Capital's largest Q2 2023 buy was Globus Medical: 59,200 shares worth $3.52M.
  • Athos Capital added most to Aerojet Rocketdyne Holdings in Q2 2023, an estimated $1.27M increase.
  • Athos Capital's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.31M.
  • Athos Capital fully exited HH&L Acquisition Co. in Q2 2023, selling an estimated $16.7M.
  • Athos Capital's ten largest holdings make up 51% of its $128M portfolio in Q2 2023.
  • Athos Capital opened 14 new positions and closed 34 in Q2 2023.
  • Athos Capital's portfolio value fell 12% quarter-over-quarter to $128M.

Based on Athos Capital's 13F filing for Q2 2023, filed 14 Aug 2023.